A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of Hyperkalemia
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the ability of RDX013 to lower serum potassium in
patients with chronic kidney disease with elevated serum potassium levels